Chemical Company of Malaysia Berhad (CCM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Chemical Company of Malaysia Berhad (CCM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012240
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chemical Company of Malaysia Berhad (CCM) is an industrial and specialty chemicals company. Its core business activities include provision of pharmaceuticals and healthcare products; chemical products and applications; and polymer coatings and applications. The company’s product range find applications in a wide range of industries. CCM develops, manufactures and manufactures generic drugs and branded pharmaceutical products; provides water treatment solutions; and the polymer coating solutions for the rubber gloves industry. It also provides over-the-counter (OTC) brands such as CHAMPS, Diamelon, Donna, Flavettes and Proviton. The company has regional offices in Singapore, Indonesia and the Philippines. CCM is headquartered in Kuala Lumpur, Malaysia.

Chemical Company of Malaysia Berhad (CCM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
Chemical Company of Malaysia to Raise USD15.79 Million in Private Placement of Shares 9
Acquisition 10
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 10
Chemical Company Of Malaysia Acquires 11.6% Stake In PanGen Biotech 12
Chemical Company of Malaysia Berhad – Key Competitors 13
Chemical Company of Malaysia Berhad – Key Employees 14
Chemical Company of Malaysia Berhad – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Strategy And Business Planning 17
Dec 07, 2016: CCM Sets up an Oncology Manufacturing Plant to Jumpstart Foray in Cancer Therapy 17
Financial Announcements 19
Aug 26, 2016: CCM’s Q2 Revenue Climbs 2.2 Per Cent To RM154.2 Million 19
Other Significant Developments 20
May 20, 2016: Perak Parkinson’s Association Takes Giant Steps To Build Coalition And Networks Globally To Promote Understanding And Treatment Of Parkinson’s 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Chemical Company of Malaysia to Raise USD15.79 Million in Private Placement of Shares 9
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 10
Chemical Company Of Malaysia Acquires 11.6% Stake In PanGen Biotech 12
Chemical Company of Malaysia Berhad, Key Competitors 13
Chemical Company of Malaysia Berhad, Key Employees 14
Chemical Company of Malaysia Berhad, Subsidiaries 15

★海外企業調査レポート[Chemical Company of Malaysia Berhad (CCM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aurora National Life Assurance Company:企業の戦略・SWOT・財務情報
    Aurora National Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Aurora National Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Dairygold Co-operative Society Ltd:企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Gold Fields Limited:企業の戦略・SWOT・財務情報
    Gold Fields Limited - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, is a clinical stage biopharmaceutical company which discovers and develops targeted cancer immunotherapies. The company’s pipeline product candidates include AFM11, AFM12, AFM13, AFM21 and AFM22, among othe …
  • BOC Hong Kong (Holdings) Ltd:戦略・SWOT・企業財務分析
    BOC Hong Kong (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary BOC Hong Kong (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PrairieSky Royalty Ltd (PSK):石油・ガス:M&Aディール及び事業提携情報
    Summary PrairieSky Royalty Ltd (PrairieSky Royalty) is an oil and gas company. The company carries out acquisition of fee simple lands from Encana Corporation and concurrent initial public offering. It also acquires and manages royalty lands, to generate free cash flow through indirect third-party o …
  • Business Development Bank Of Canada
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Australia and New Zealand Banking Group Ltd:企業の戦略・SWOT・財務情報
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • WidePoint Corp (WYY):企業の財務・戦略的SWOT分析
    Summary WidePoint Corp (WidePoint) operates as a technology company that provides telecommunications lifecycle management, managed mobility, and cybersecurity solutions. The company offers solutions such as telecom expense management, identity management solutions, mobile security solutions, cyberse …
  • State Oil Company of Azerbaijan Republic:企業のM&A・事業提携・投資動向
    State Oil Company of Azerbaijan Republic - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Oil Company of Azerbaijan Republic Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務情報
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Lawson Inc:企業の戦略・SWOT・財務分析
    Lawson Inc - Strategy, SWOT and Corporate Finance Report Summary Lawson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kinnov Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors …
  • GKE Corporation Limited (595):企業の財務・戦略的SWOT分析
    GKE Corporation Limited (595) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Eckoh PLC (ECK):企業の財務・戦略的SWOT分析
    Summary Eckoh PLC (Eckoh) is a technology service provider that offers secure payment products and customer service solutions. The company provides agent assisted payments, IVR payments, mobile and web payments and GPDR. Its agent assisted payments include DTMF Masking, audio tokenization, alternati …
  • Ethicon US LLC:医療機器:M&Aディール及び事業提携情報
    Summary Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocar …
  • Rentech Inc (RTKH)-エネルギー分野:企業M&A・提携分析
    Summary Rentech, Inc. (Rentech) is a provider of wood fibre processing services, wood chips and wood pellets. It offers a wide range of integrated wood fibre services such as wood chipping, trading, vessel loading, operations, and marketing through its subsidiary, Fulghum Fibres, primarily to the pu …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Deutsche Bank AG:企業のM&A・事業提携・投資動向
    Deutsche Bank AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Bank AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆